Imaging

ClinicalJuly 17, 2026

NIMH Initiates PET Imaging Study with New Tracer 11C-ARMI for Brain Research

The National Institute of Mental Health is testing a new radioactive tracer, 11C-ARMI, in healthy individuals to evaluate its effectiveness in imaging brain function.

Companies

Assets

Recent signals(12)

Novel MRI Methods for Liver Disease Biomarkers Under Evaluation

FDA Approves Supplement for Gadobutrol by Hengrui Pharma

FDA Accepts Supplement for GADAVIST by Bayer Healthcare

NIMH Initiates PET Imaging Study with New Tracer 11C-ARMI for Brain Research

FDA Accepts Supplement Application for Gadobutrol by Hengrui Pharma

FDA Grants Approval for PIXXOSCAN (Gadobutrol) by GE Healthcare

Study Evaluates Safety of Cardiac MRI in High-Risk Patients with Implanted Leads

FDA Acceptance of Iohexol Supplement Application by Amneal

NHLBI Launches Study on 18F-FAPI-74 PET/CT Imaging for Early Detection of Fibrosis

FDA Grants Approval for Gadobutrol ANDA219146 by Zenara

First-in-human study of NTSR1-targeted imaging in prostate cancer shows promise

FDA Grants Approval for Gadobutrol ANDA219287 by Viwit Pharm

Upcoming catalysts

Indications

Get signals before the market moves